Comparison of Clinical Outcomes of Prostatic Artery Embolization with 50-μm Plus 100-μm Polyvinyl Alcohol (PVA) Particles versus 100-μm PVA Particles Alone: A Prospective Randomized Trial

Journal of Vascular and Interventional Radiology - Tập 29 - Trang 1694-1702 - 2018
Mao Qiang Wang1, Jin Long Zhang1, Hai Nan Xin1, Kai Yuan1, Jieyu Yan1, Yan Wang1, Guo Dong Zhang1, Jin Xin Fu1
1Department of Interventional Radiology, Chinese PLA General Hospital, Beijing 100853, P.R. China

Tài liệu tham khảo

Pisco, 2013, Prostatic arterial embolization for benign prostatic hyperplasia: short- and intermediate-term results, Radiology, 266, 668, 10.1148/radiol.12111601 Carnevale, 2013, Quality of life and clinical symptom improvement support prostatic artery embolization for patients with acute urinary retention caused by benign prostatic hyperplasia, J Vasc Interv Radiol, 24, 535, 10.1016/j.jvir.2012.12.019 Bagla, 2014, Early results from a United States trial of prostatic artery embolization in the treatment of benign prostatic hyperplasia, J Vasc Interv Radiol, 25, 47, 10.1016/j.jvir.2013.09.010 Gao, 2014, Benign prostatic hyperplasia: prostatic arterial embolization versus transurethral resection of the prostate—a prospective, randomized, and controlled clinical trial, Radiology, 270, 920, 10.1148/radiol.13122803 Wang, 2015, Prostatic arterial embolization for the treatment of lower urinary tract symptoms due to large (>80 mL) benign prostatic hyperplasia: results of midterm follow-up from Chinese population, BMC Urol, 15, 33, 10.1186/s12894-015-0026-5 Bilhim, 2016, Predictors of clinical outcome after prostate artery embolization with spherical and nonspherical polyvinyl alcohol particles in patients with benign prostatic hyperplasia, Radiology, 281, 289, 10.1148/radiol.2016152292 Pisco, 2016, Medium- and long-term outcome of prostate artery embolization for patients with benign prostatic hyperplasia: results in 630 patients, J Vasc Interv Radiol, 27, 1115, 10.1016/j.jvir.2016.04.001 Uflacker, 2016, Meta-analysis of prostatic artery embolization for benign prostatic hyperplasia, J Vasc Interv Radiol, 27, 1686, 10.1016/j.jvir.2016.08.004 Shim, 2017, Efficacy and safety of prostatic arterial embolization: systematic review with meta-analysis and meta-regression, J Urol, 197, 465 Bilhim, 2013, Does polyvinyl alcohol particle size change the outcome of prostatic arterial embolization for benign prostatic hyperplasia? Results from a single-center randomized prospective study, J Vasc Interv Radiol, 24, 1595, 10.1016/j.jvir.2013.06.003 Gonçalves, 2016, Comparative study using 100–300 versus 300–500 μm microspheres for symptomatic patients due to enlarged-BPH prostates, Cardiovasc Intervent Radiol, 39, 1372, 10.1007/s00270-016-1443-x Sun, 2016, Prostatic artery embolization (PAE) for symptomatic benign prostatic hyperplasia (BPH): part 1, pathological background and clinical implications, Cardiovasc Intervent Radiol, 39, 1, 10.1007/s00270-015-1233-x Li, 2015, Prostatic arterial embolization with small sized particles for the treatment of lower urinary tract symptoms due to large benign prostatic hyperplasia: preliminary results, Chin Med J (Engl), 128, 2072, 10.4103/0366-6999.161370 Carnevale, 2017, Recurrence of lower urinary tract symptoms following prostate artery embolization for benign hyperplasia: single center experience comparing two techniques, Cardiovasc Intervent Radiol, 40, 366, 10.1007/s00270-017-1569-5 Angle, 2010, Quality improvement guidelines for percutaneous transcatheter embolization: Society of Interventional Radiology Standards of Practice Committee, J Vasc Interv Radiol, 21, 1479, 10.1016/j.jvir.2010.06.014 Grosso, 2015, Prostatic artery embolization in benign prostatic hyperplasia: preliminary results in 13 patients, Radiol Med, 120, 361, 10.1007/s11547-014-0447-3 Pisco, 2013, Embolisation of prostatic arteries as treatment of moderate to severe lower urinary symptoms (LUTS) secondary to benign hyperplasia: results of short- and mid-term follow-up, Eur Radiol, 23, 2561, 10.1007/s00330-012-2714-9 Lin, 2016, Can prostatic arterial embolisation (PAE) reduce the volume of the peripheral zone? MRI evaluation of zonal anatomy and infarction after PAE, Eur Radiol, 26, 3466, 10.1007/s00330-015-4177-2 Frenk, 2014, MRI findings after prostatic artery embolization for treatment of benign hyperplasia, AJR Am J Roentgenol, 203, 813, 10.2214/AJR.13.11692 Kisilevzky, 2016, MRI assessment of prostatic ischaemia: best predictor of clinical success after prostatic artery embolisation for benign prostatic hyperplasia, Clin Radiol, 71, 876, 10.1016/j.crad.2016.05.003 Wang, 2017, Benign prostatic hyperplasia: cone-beam CT in conjunction with DSA for identifying prostatic arterial anatomy, Radiology, 282, 271, 10.1148/radiol.2016152415 Bilhim, 2012, Prostatic arterial supply: anatomic and imaging findings relevant for selective arterial embolization, J Vasc Interv Radiol, 23, 1403, 10.1016/j.jvir.2012.07.028 Garcia-Monaco, 2014, Human cadaveric specimen study of the prostatic arterial anatomy: implications for arterial embolization, J Vasc Interv Radiol, 25, 315, 10.1016/j.jvir.2013.10.026 Moreira, 2017, A review of adverse events related to prostatic artery embolization for treatment of bladder outlet obstruction due to BPH, Cardiovasc Intervent Radiol, 40, 1490, 10.1007/s00270-017-1765-3